(Q41787003)

9 October 2017

title

Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites (English)

1 reference

9 October 2017

1

Quirion R

1 reference

9 October 2017

Lafaille F

2

1 reference

9 October 2017

Nair NP

series ordinal

3

1 reference

9 October 2017

publication date

1 June 1985

1 reference

Journal of Pharmacy and Pharmacology

9 October 2017

published in

1 reference

9 October 2017

volume

37

1 reference

9 October 2017

issue

6

1 reference

9 October 2017

page(s)

437-440

1 reference

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

9 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

The effects of lesions in the rat hippocampus suggest the association of calcium channel blocker binding sites with specific neuronal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Molecular pathology of schizophrenia: more than one disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Adrenergic stimulation of isolated rat gastric mucosal cells. Effect on adenylate cyclase and 14C-aminopyrine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Identification of putative calcium channels in skeletal muscle microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Sites of action of Ca2+ channel inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

New developments in calcium ion channel antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Binding of [3H]nimodipine to cardiac and smooth muscle membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Are dihydropyridine binding sites voltage sensitive calcium channels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Calcium antagonist receptor binding sites labeled with [3H]nitrendipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Autoradiographic visualization of [3H]nitrendipine binding sites in rat brain: localization to synaptic zones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

A unitary mechanism of calcium antagonist drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Effects of pimozide on the response of smooth muscle to non-dopamine agonists and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

3Hverapamil binding sites in brain and skeletal muscle: Regulation by calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

Calcium channels: direct identification with radioligand binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1985.TB03033.X

10.1111/J.2042-7158.1985.TB03033.X

21 January 2018

Identifiers

DOI

1 reference

9 October 2017

1 reference